---

Respiratory Pathology for Nursing: COPD, Asthma, and Pneumonia

---

1. COPD (Chronic Obstructive Pulmonary Disease)

Definition and Spectrum

• Emphysema - damage to lung parenchyma
• Chronic Bronchitis - abnormalities of the tracheobronchial tree

Pathophysiology

• Goblet cell metaplasia (Clara cells replaced by mucus-secreting cells)
• Inflammatory cell infiltration of airway walls
• Lymphoid follicle formation in severe disease
• Mucus plug accumulation (strongly associated with airflow limitation in severe COPD)
• Loss of alveolar attachments to bronchioles - contributing to airway collapse

Diagnosis (Spirometry)

• Post-bronchodilator FEV1/FVC < 0.70 is the hallmark diagnostic criterion (GOLD guidelines)
• Unlike asthma, airflow limitation in COPD persists despite bronchodilators
• GOLD staging classifies severity by FEV1 % predicted: mild (≥80%), moderate (50-79%), severe (30-49%), very severe (<30%)

Epidemiology

• Affects over 400 million people worldwide
• Now ranked the 3rd leading cause of death globally (after cardiovascular disease and stroke)

---

2. Asthma

Pathophysiology

• Airway inflammation - Type 2 (eosinophilic) inflammation driven by IgE-mediated mast cell activation, eosinophil recruitment, and Th2 cytokines (IL-4, IL-5, IL-13)
• Bronchoconstriction - smooth muscle spasm causing reversible narrowing
• Mucus hypersecretion - goblet cell hyperplasia, mucus plug formation
• Airway remodeling (in chronic/severe asthma) - basement membrane thickening, smooth muscle hypertrophy

Key Distinction from COPD

Note: Asthma-COPD overlap (ACO) exists - patients can have features of both, particularly smokers with longstanding asthma. - Harrison's Principles of Internal Medicine 22E (2025)

---

3. Pneumonia

Types and Distribution

Stages of Lobar Pneumonia (Classic 4 Stages)

1. Congestion - lung is heavy, wet, red; vascular engorgement; intra-alveolar fluid with few neutrophils; numerous bacteria
2. Red hepatization - massive confluent exudation; neutrophils, red cells, and fibrin fill alveolar spaces; lobe is red, firm, airless with liver-like consistency
3. Gray hepatization - red cells disintegrate; fibrinopurulent exudate persists; color changes to grayish brown
4. Resolution - exudate broken down by enzymatic digestion; debris resorbed, ingested by macrophages, expectorated, or organized by fibroblasts

Complications of Pneumonia

1. Abscess formation - tissue destruction and necrosis
2. Empyema - spread to pleural cavity with fibrinopurulent reaction
3. Bacteremic dissemination - to heart valves, brain, kidneys, spleen, joints (causing endocarditis, meningitis, septic arthritis)

Clinical Features

• Typical (bacterial): Abrupt onset, high fever, shaking chills, cough with mucopurulent sputum, possible hemoptysis, pleuritic chest pain
• Lobar pattern generally indicates bacterial process; interstitial infiltrates suggest atypical/viral pathogens

---

Nursing Assessment Summary

---

• Fishman's Pulmonary Diseases and Disorders - COPD pathophysiology, airflow obstruction
• Robbins & Kumar Basic Pathology - Pneumonia morphology and stages
• Murray & Nadel's Textbook of Respiratory Medicine - Airflow limitation and respiratory evaluation
• Harrison's Principles of Internal Medicine 22E (2025) - Asthma-COPD overlap

---

How to Attempt a Pathology Exam

Before the Exam - Preparation Strategy

Know Your Exam Format

---

During the Exam - General Rules

1. Read the Question Carefully

• Identify the action word: describe, enumerate, discuss, compare, classify
• Each word demands a different response type:
  • Enumerate - list only, no explanation needed
  • Describe - explain in detail
  • Discuss - write pros/cons, mechanisms, clinical relevance
  • Compare - use a table or parallel points
  • Classify - group into categories first, then explain

2. Time Management

• Divide total time by number of questions before you start
• Keep 10-15 minutes at the end for review
• If stuck on a question, skip and return - do not waste time
• For MCQs: roughly 1-1.5 minutes per question

---

Answering Specific Question Types

Long Answer / Essay Questions (Pathology specific)

1. Definition
2. Etiology / Causes
3. Pathogenesis (mechanism)
4. Morphology (gross + microscopic findings)
5. Clinical features
6. Complications
7. Diagnosis / Lab findings
8. Treatment (brief, if asked)

• Definition: Acute bacterial infection consolidating an entire lobe
• Etiology: Streptococcus pneumoniae most common
• Pathogenesis: Aspiration → bacterial proliferation → inflammatory response
• Morphology: 4 stages - congestion, red hepatization, gray hepatization, resolution
• Complications: Abscess, empyema, bacteremia

Short Answer Questions (SAQs)

• Write in numbered/bulleted points - easier to mark
• Put the most important point first
• Aim for 5-8 solid points rather than padding with vague sentences
• Use bold or underline key terms (if handwritten - underline)

MCQs

• Use elimination - rule out clearly wrong options first
• Watch for absolutes: "always," "never," "only" - these are often wrong
• In pathology, the most common answer is often correct (e.g., most common cause of X)
• Trust your first instinct - change answers only if you are certain

Spot / Practical Exam (Histology Slides or Gross Specimens)

1. Organ identification - which organ/tissue?
2. Gross/Macro features - size, color, texture, shape, cut surface
3. Microscopic features - cell type, pattern, inflammatory cells, necrosis, fibrosis
4. Diagnosis - name the condition
5. One key differentiating feature that confirms your diagnosis

---

Pathology-Specific Tips

Use Pathology's Own Language

Common High-Yield Pathology Topics for Nursing Exams

• Inflammation (acute vs. chronic, types of exudate)
• Cell injury and necrosis
• Neoplasia (benign vs. malignant, spread)
• Respiratory: COPD, asthma, pneumonia, TB
• Cardiovascular: MI, atherosclerosis, heart failure
• Infections: bacterial, viral, fungal patterns
• Fluid imbalances: edema, shock

---

Writing Technique

• Start with a brief definition - even 1 sentence shows you know the topic
• Use headings and subheadings - organizes your answer and signals competence
• Draw a diagram or flowchart where appropriate (pathogenesis steps, staging, cascades) - these impress examiners and save words
• Always write complications - many students forget this and lose easy marks
• Clinical correlation at the end (what symptom does this pathology cause?) earns extra marks in applied questions

---

Common Mistakes to Avoid

---

Day-Before Strategy

1. Do not try to learn new topics
2. Revise morphology sections - these are direct, easy marks
3. Review your own short notes / mnemonics
4. Sleep well - recall drops sharply with poor sleep

---

---

OBSTRUCTIVE LUNG DISEASES - Complete Pathology Notes

All four are obstructive diseases: FEV1/FVC < 0.70, with increased airway resistance and air trapping.

---

1. CHRONIC BRONCHITIS

1. Definition

2. Etiology / Causes

• Tobacco smoke - primary cause (90% of patients are smokers)
• Occupational dust: grain, cotton, silica
• Air pollutants: sulfur dioxide, nitrogen dioxide
• Recurrent respiratory infections (maintain and exacerbate, do not initiate)

3. Pathogenesis

4. Morphology

• Hyperemia, swelling, edema of mucous membranes
• Excessive mucinous or mucopurulent secretions
• Thick casts of secretions filling bronchi and bronchioles

• Chronic inflammation of airways (lymphocytes, macrophages)
• Goblet cell hyperplasia (in small airways)
• Enlargement of mucus-secreting submucosal glands - key finding
• Reid index > 0.4 (ratio of mucous gland thickness to bronchial wall thickness - normally 0.4; increased in proportion to disease severity)
• Smooth muscle hypertrophy and peribronchial fibrosis
• Squamous metaplasia and dysplasia of bronchial epithelium
• Severe cases: bronchiolitis obliterans (total obliteration of small bronchioles by fibrosis)

5. Clinical Features

• "Blue Bloater" - classic description
• Persistent productive cough (early symptom; copious sputum)
• Hypoxemia and hypercapnia → cyanosis
• Dyspnea (mild, late onset)
• Frequent respiratory infections
• Wheezing (due to airway narrowing)
• Age of onset: 40-45 years

6. Complications

• Cor pulmonale (common) → right heart failure
• Pulmonary hypertension
• Recurrent chest infections
• Respiratory failure
• Polycythemia (secondary, due to chronic hypoxia)
• Progression to severe COPD

7. Diagnosis / Lab Findings

• Spirometry: FEV1/FVC < 0.70 (post-bronchodilator); FEV1 reduced; does NOT significantly reverse with bronchodilators
• Chest X-ray: Prominent vascular markings ("dirty chest"), large heart
• ABG: Hypoxemia (↓PaO2), hypercapnia (↑PaCO2)
• Sputum culture: Identifies infecting organisms
• Reid index > 0.4 on biopsy

8. Treatment

• Smoking cessation (most important)
• Long-acting bronchodilators (LABA, LAMA)
• Inhaled corticosteroids (for frequent exacerbations)
• Antibiotics (for acute exacerbations)
• Supplemental oxygen (long-term, if PaO2 < 55 mmHg)
• Pulmonary rehabilitation
• Vaccinations (influenza, pneumococcal)

---

2. EMPHYSEMA

1. Definition

2. Etiology / Causes

• Cigarette smoking (primary cause - centriacinar type)
• α1-antitrypsin deficiency (genetic - panacinar type; ~1% of emphysema cases; ZZ genotype)
• Other inhaled pollutants
• Rare: intravenous drug use (panacinar, lower lobe)

3. Pathogenesis

Smoking / Noxious particles
        ↓
Inflammatory cells recruited (neutrophils, macrophages, CD4+/CD8+ T cells)
        ↓
Release of PROTEASES (especially elastase)
        ↓
Breakdown of elastic tissue in alveolar walls
        ↓
↓ Elastic recoil → airway collapse on expiration
        ↓
EMPHYSEMA (permanent airspace enlargement)

4. Morphology

• Voluminous, overinflated lungs overlapping the heart anteriorly
• Flattened diaphragm
• Large alveoli visible on cut surface
• Apical blebs or bullae in advanced disease

• Destruction of alveolar walls without fibrosis (key distinguishing feature)
• Enlarged airspaces
• Loss of elastic tissue
• Centriacinar: upper 2/3 of lungs more affected; lungs deeper pink
• Panacinar: lungs pale, voluminous; lower lobes more affected

5. Clinical Features

• "Pink Puffer" - classic description
• Barrel chest (increased AP diameter due to air trapping)
• Severe progressive dyspnea (early onset)
• Pursed-lip breathing (to maintain airway patency)
• Hunched-over posture (tripod position)
• Cough - late, scanty sputum
• Weight loss (can be severe, suggesting occult cancer)
• Prolonged expiration
• Blood gases relatively normal at rest (compensated)
• Low diffusion capacity (DLCO reduced)

6. Complications

• Spontaneous pneumothorax (rupture of subpleural blebs)
• Pulmonary hypertension and cor pulmonale (end-stage)
• Respiratory failure
• Fatal pneumothorax
• Mucus plug formation → increased mortality
• Secondary polycythemia

7. Diagnosis / Lab Findings

• Spirometry: FEV1/FVC < 0.70; FEV1 reduced; low elastic recoil
• Chest X-ray / CT: Hyperinflation, flattened diaphragm, bullae, normal heart size, decreased vascular markings
• DLCO: Reduced (loss of alveolar surface)
• ABG: Normal to mild hypoxemia at rest; worsens with exercise
• α1-antitrypsin levels: Check in young patients or non-smokers
• Lung volume studies: Increased TLC, RV (air trapping)

8. Treatment

• Smoking cessation
• Long-acting bronchodilators (LABA + LAMA)
• Inhaled corticosteroids
• Supplemental oxygen
• Bullectomy (for large bullae compressing normal tissue)
• Lung volume reduction surgery (selected patients)
• Lung transplantation (end-stage)
• α1-antitrypsin replacement therapy (for deficiency cases)

---

3. BRONCHIAL ASTHMA

1. Definition

2. Etiology / Causes

3. Pathogenesis

• Allergen → sensitization → allergen-specific IgE binds to mast cells
• Re-exposure → mast cell degranulation
• Release of: histamine, leukotrienes (C4, D4, E4), prostaglandin D2
• Results in: bronchoconstriction, increased mucus production, vasodilation, vascular permeability

• Recruitment of eosinophils, neutrophils, more Th2 cells
• Eosinophils release: major basic protein, galectin-10 (forms Charcot-Leyden crystals)
• IL-5 sustains eosinophil activity
• Mediators: LTC4, LTD4, LTE4 - prolonged bronchoconstriction + ↑ mucus secretion
• Acetylcholine from parasympathetic nerves → smooth muscle constriction (muscarinic receptors)

1. Leukotrienes C4, D4, E4 - bronchoconstriction + mucus secretion
2. Acetylcholine - smooth muscle spasm
3. IL-5 - eosinophil activation (anti-IL-5 biologics work)
4. Galectin-10 / Charcot-Leyden crystals - strong inducers of inflammation and mucus

4. Morphology

• Overinflated lungs with small areas of atelectasis
• Bronchi and bronchioles occluded by thick, tenacious mucus plugs
• Shed epithelium within mucus plugs

• Goblet cell hyperplasia (excess mucus production)
• Sub-basement membrane fibrosis (Type I and III collagen deposition) - hallmark
• Smooth muscle hypertrophy and hyperplasia
• Increased vascularity
• Enlarged submucosal glands
• Eosinophilic inflammation (eosinophils in airway wall - key difference from chronic bronchitis)
• Curschmann spirals in sputum (coiled mucus from subepithelial ducts)
• Charcot-Leyden crystals (galectin-10 from eosinophils)

5. Clinical Features

• Episodic attacks of: chest tightness, dyspnea, wheezing, cough
• Symptoms worst at night or early morning
• Prolonged expiration (expiratory wheeze)
• Between attacks: patient may be asymptomatic
• Status asthmaticus: unrelenting attack lasting days/weeks → cyanosis, death
• Peripheral blood eosinophilia (atopic type)
• Curschmann spirals and Charcot-Leyden crystals in sputum

6. Complications

• Status asthmaticus (life-threatening)
• Respiratory failure / death
• Pneumothorax (rare, from mucus plugging)
• Atelectasis
• Chronic airflow limitation (airway remodeling adds irreversible component)
• Cor pulmonale (rare, late)

7. Diagnosis / Lab Findings

• Spirometry: FEV1/FVC < 0.70 during attack; reversible with bronchodilator (≥12% and ≥200 mL improvement = diagnostic)
• Peak flow monitoring: Diurnal variability >20% is characteristic
• Methacholine challenge test: Positive (AHR)
• Allergy tests: Elevated total serum IgE; RAST (allergen-specific IgE); skin prick test (wheal-and-flare)
• CBC: Peripheral eosinophilia (atopic asthma)
• Sputum: Eosinophils, Curschmann spirals, Charcot-Leyden crystals
• Chest X-ray: Hyperinflation during attack; usually normal between attacks

8. Treatment

• Short-acting bronchodilators (SABA) - salbutamol (albuterol): rescue therapy
• Inhaled corticosteroids - cornerstone of maintenance (anti-inflammatory)
• Leukotriene antagonists - montelukast
• Long-acting bronchodilators (LABA) - salmeterol: add-on to ICS
• Biologics (severe asthma): Anti-IL-4R (dupilumab), anti-IL-5 (mepolizumab), anti-IgE (omalizumab), anti-TSLP (tezepelumab)
• Avoid triggers (allergen avoidance)
• Patient education: peak flow monitoring, action plans

---

4. BRONCHIECTASIS

1. Definition

2. Etiology / Causes

1. Congenital/hereditary conditions predisposing to chronic infection:

• Cystic fibrosis (most common in developed world)
• Primary ciliary dyskinesia / Kartagener syndrome (bronchiectasis + situs inversus + sinusitis)
• Immunodeficiency states (hypogammaglobulinemia)
• Intralobar pulmonary sequestration

1. Severe necrotizing pneumonia - bacterial, viral, or fungal (single severe or recurrent episodes)
2. Bronchial obstruction - tumor, foreign body, mucus impaction (localized bronchiectasis)
3. Immune disorders - rheumatoid arthritis, SLE, inflammatory bowel disease, post-transplant
4. Up to 50% of cases are idiopathic
5. Allergic bronchopulmonary aspergillosis (ABPA) - Aspergillus sensitization → Th2 response, high IgE, eosinophils, mucus plugs

3. Pathogenesis

Defective airway clearance
(thick mucus / ciliary dysfunction / obstruction)
          ↓
Pooling of secretions distal to obstruction
          ↓
Chronic bacterial infection (H. influenzae 50%, P. aeruginosa 12-30%)
          ↓
Persistent inflammation in airway wall
          ↓
Destruction of smooth muscle and elastic tissue
          ↓
PERMANENT DILATION OF BRONCHI AND BRONCHIOLES
          ↓
Smaller bronchioles obliterated by fibrosis (bronchiolitis obliterans)

4. Morphology

• Usually affects lower lobes bilaterally (vertical airways; most affected by gravitational drainage)
• Airways dilated up to 4 times normal size
• Bronchi traceable almost to pleural surface (normally invisible within 2-3 cm of pleura)
• Dilated bronchi appear cystic, filled with mucopurulent secretions on cut surface
• When caused by obstruction: localized to the obstructed segment

• Acute and chronic inflammatory exudate in bronchial/bronchiolar walls
• Desquamation of lining epithelium
• Extensive ulceration
• Squamous metaplasia (response to chronic inflammation - further reduces mucociliary clearance)
• Necrosis → abscess formation in severe cases
• Peribronchiolar fibrosis in chronic cases
• Bronchiolar lumen: subtotal or total obliteration (bronchiolitis obliterans)

5. Clinical Features

• Severe persistent cough (hallmark)
• Expectoration of foul-smelling, purulent sputum (large volumes - "3 layers" on standing: top frothy, middle mucoid, bottom purulent)
• Hemoptysis (sometimes massive)
• Dyspnea and orthopnea in severe cases
• Paroxysms of cough worst in morning (positional drainage of pooled secretions on rising)
• Symptoms episodic, precipitated by upper respiratory tract infections
• Obstructive respiratory insufficiency → marked dyspnea and cyanosis
• Clubbing of fingers (chronic hypoxia)
• Coarse crepitations on auscultation

6. Complications

• Cor pulmonale and right heart failure
• Brain abscess (hematogenous spread)
• Amyloidosis (secondary / AA amyloidosis from chronic infection)
• Empyema
• Pneumonia (recurrent)
• Respiratory failure
• Massive hemoptysis

Note: With modern antibiotics and physiotherapy, cor pulmonale, brain abscesses, and amyloidosis are now less frequent than in the past.

7. Diagnosis / Lab Findings

• HRCT chest (High-resolution CT): Gold standard - shows signet-ring sign (dilated bronchus with adjacent artery), "tram-track" lines, cystic spaces
• Chest X-ray: Increased bronchial markings, "ring shadows," "tramline shadows"
• Spirometry: Obstructive pattern (FEV1/FVC < 0.70); may have mixed obstructive-restrictive
• Sputum culture: H. influenzae, P. aeruginosa, nontuberculous mycobacteria
• Sweat chloride test: To exclude cystic fibrosis
• Serum immunoglobulins: To exclude immunodeficiency
• Ciliary biopsy / electron microscopy: To diagnose primary ciliary dyskinesia
• Serum IgE + Aspergillus precipitins: To diagnose ABPA

8. Treatment

• Airway clearance (chest physiotherapy, postural drainage) - cornerstone
• Antibiotics: Targeted to sputum organisms; long-term rotating antibiotics in severe cases; inhaled tobramycin for P. aeruginosa
• Bronchodilators (if reversible component present)
• Treatment of underlying cause (e.g., CFTR modulators for cystic fibrosis - ivacaftor/lumacaftor)
• Surgery: Lobectomy or segmentectomy for localized severe disease
• Lung transplantation: End-stage (especially cystic fibrosis)
• Vaccinations, nutritional support

---

Quick Comparison Table

---